Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Chène

Showing results (11-20 of 57) with videos related to

Pageof 6
Sort By:
Oncology Research|March 21, 2008
Cellular studies of MrDb (DDX18)Sandy Dubaele, Patrick Chène
Archives of Biochemistry and Biophysics|August 25, 2024
Study of the TEAD-binding domain of the VGLL1, VGLL2 and VGLL3 proteins from vertebratesYannick Mesrouze, Patrick Chène
Biochemical and Biophysical Research Communications|January 31, 2006
Study of the ATP-binding site of helicase IV from Escherichia coliSandy Dubaele, Claude Lourdel, Patrick Chène
Journal of Biochemistry and Molecular Biology|January 25, 2007
Biochemical study of recombinant PcrA from Staphylococcus aureus for the development of screening assaysSandy Dubaele, Christophe Martin, Jacqueline Bohn, et al.
The Journal of Peptide Research : Official Journal of the American Peptide Society|July 10, 2002
Aib-based peptide backbone as scaffolds for helical peptide mimicsRaja Banerjee, Gautam Basu, Patrick Chène, et al.
Bioorganic & Medicinal Chemistry Letters|June 30, 2009
Discovery of a new class of catalytic topoisomerase II inhibitors targeting the ATP-binding site by structure based design. Part IPascal Furet, Joseph Schoepfer, Thomas Radimerski, et al.
Bioorganic & Medicinal Chemistry Letters|November 23, 2005
Inhibition of DNA helicases with DNA-competitive inhibitorsSandy Dubaele, Wolfang Jahnke, Joseph Schoepfer, et al.
FEBS Letters|October 10, 2002
Study of the cytotoxic effect of a peptidic inhibitor of the p53-hdm2 interaction in tumor cellsPatrick Chène, Jean Fuchs, Ilaria Carena, et al.
British Journal of Pharmacology|April 25, 2017
A critical assessment of the synthesis and biological activity of p53/human double minute 2-stapled peptide inhibitorsRike Wallbrecher, Patrick Chène, Stephan Ruetz, et al.
Protein Science : a Publication of the Protein Society|June 2, 2021
Biochemical properties of VGLL4 from Homo sapiens and Tgi from Drosophila melanogaster and possible biological implicationsYannick Mesrouze, Marco Meyerhofer, Catherine Zimmermann, et al.
Pageof 6

Showing results (11-20 of 57) with videos related to

Sort By:
Pageof 6
Oncology Research|March 21, 2008
Cellular studies of MrDb (DDX18)Sandy Dubaele, Patrick Chène
Archives of Biochemistry and Biophysics|August 25, 2024
Study of the TEAD-binding domain of the VGLL1, VGLL2 and VGLL3 proteins from vertebratesYannick Mesrouze, Patrick Chène
Biochemical and Biophysical Research Communications|January 31, 2006
Study of the ATP-binding site of helicase IV from Escherichia coliSandy Dubaele, Claude Lourdel, Patrick Chène
Journal of Biochemistry and Molecular Biology|January 25, 2007
Biochemical study of recombinant PcrA from Staphylococcus aureus for the development of screening assaysSandy Dubaele, Christophe Martin, Jacqueline Bohn, et al.
The Journal of Peptide Research : Official Journal of the American Peptide Society|July 10, 2002
Aib-based peptide backbone as scaffolds for helical peptide mimicsRaja Banerjee, Gautam Basu, Patrick Chène, et al.
Bioorganic & Medicinal Chemistry Letters|June 30, 2009
Discovery of a new class of catalytic topoisomerase II inhibitors targeting the ATP-binding site by structure based design. Part IPascal Furet, Joseph Schoepfer, Thomas Radimerski, et al.
Bioorganic & Medicinal Chemistry Letters|November 23, 2005
Inhibition of DNA helicases with DNA-competitive inhibitorsSandy Dubaele, Wolfang Jahnke, Joseph Schoepfer, et al.
FEBS Letters|October 10, 2002
Study of the cytotoxic effect of a peptidic inhibitor of the p53-hdm2 interaction in tumor cellsPatrick Chène, Jean Fuchs, Ilaria Carena, et al.
British Journal of Pharmacology|April 25, 2017
A critical assessment of the synthesis and biological activity of p53/human double minute 2-stapled peptide inhibitorsRike Wallbrecher, Patrick Chène, Stephan Ruetz, et al.
Protein Science : a Publication of the Protein Society|June 2, 2021
Biochemical properties of VGLL4 from Homo sapiens and Tgi from Drosophila melanogaster and possible biological implicationsYannick Mesrouze, Marco Meyerhofer, Catherine Zimmermann, et al.
Pageof 6